U.S. Anti-Aging Market Surges with Skincare and Injectables

U.S. Anti-Aging Market Size, Key Players with Dynamics

The U.S. anti-aging market size is calculated at US$ 20.21 billion in 2024, grew to US$ 21.61 billion in 2025, and is projected to reach around US$ 39.6 billion by 2034. The market is expanding at a CAGR of 6.95% between 2025 and 2034.

The growing aging population and awareness are increasing the use of anti-aging products. This, in turn, is driving their innovations to provide long-term action with fewer or no side effects. At the same time, AI is also being used to enhance drug discovery and development. Moreover, the growing investments and collaboration are enhancing their development and innovations. The companies are further contributing by launching new anti-aging products, and all these advancements are promoting the market growth.

Key Takeaways

• U.S. anti-aging market to crossed USD 20.21 billion by 2024.
• Market projected at USD 39.6 billion by 2034.
• CAGR of 6.95% expected in between 2025 to 2034.
• The global anti-aging market is expected to grow from US$ 75.78 billion in 2024 to US$ 129.88 billion by 2034 at a 5.54% CAGR.
• By product/treatment type, the topical skincare segment held an approximate 48% share in the U.S. anti-aging market in 2024.
• By product/treatment type, the injectables segment is expected to be the fastest growing during the forecast period.
• By channel/distribution type, the retail segment held approximately a 54% share in the market in 2024.
• By channel/distribution type, the medical aesthetics clinics/dermatology practices segment is expected to be the fastest growing during the forecast period.
• By age/demographic type, the women 35–64 segment held an approximate 60% share in the market in 2024.
• By age/demographic type, the younger prevention (25–34) segment is expected to be the fastest growing during the forecast period.
• By technology/science platform type, the actives & formulation chemistry held approximately a 50% share in the U.S. anti-aging market in 2024.
• By technology/science platform type, the biotech-derived injectables & biostimulators segment is expected to be the fastest growing during the forecast period.
• By end user/buyer type, the individual consumers segment held an approximate 54% share in the global U.S. anti-aging market in 2024.
• By end user/buyer type, the dermatology & medical aesthetic clinics segment is expected to be the fastest growing during the forecast period.

Quick Facts Table

What are Anti-Aging Products?

The U.S. anti-aging market is driven by growing consumer skincare awareness, increasing innovations in beauty and medicines, and increasing elderly populations. The U.S. anti-aging covers consumer and clinical products, devices, and services aimed at preventing, slowing, or reversing visible and biological signs of aging.

It spans topical skincare (creams, serums, moisturizers with retinoids, peptides, vitamin C, AHAs, niacinamide), cosmeceuticals, ingestible nutraceuticals (collagen, omega-3s, anti-oxidant supplements), prescription dermatology (topical Rx, tretinoin, peptide therapies), medical aesthetic injectables (neuromodulators and dermal fillers), energy-based aesthetic devices (lasers, RF, HIFU), and clinical regenerative approaches (PRP, micro-needling with growth factors, early cell/peptide therapies). The market is a hybrid of retail (mass & prestige), medical-aesthetic channels, and professional/clinic revenue streams.

U.S. Anti-Aging Market Outlook

• Industry Growth Overview: The industry is expected to see significant growth in non-invasive treatments and personalized medication with enhanced effectiveness. Growth is being driven by a growing geriatric population and growing consumer interest in corrective and preventive skincare.
• Sustainability Trends: The market is promoting the sustainability trends due to growing consumer demand for organic or natural products. The companies are also focusing on formulations that are free from harmful chemicals and eco-friendly, as well as encouraging sustainable packaging and sourcing practices. 
• Startup Ecosystem: The startup ecosystem is focusing on innovations such as cellular rejuvenation, personalized antiaging solutions, and epigenetics. Moreover, the support provided by the investment is functioning and enhancing their development.

What are the AI Technological Shifts in the U.S. Anti-Aging Market?

The use of AI is increasing to discover drug candidates to develop effective anti-aging products. It is also being used to develop drugs that show targeted action depending on the pathways or to target multiple age-related biological pathways at once. At the same time, along with the use of machine learning, it is being used to analyze the datasets, optimize the formulation, target specific proteins, and develop models.

For instance, 

• In May 2025, the collaboration between Scripps Research and Gero, which is a biotechnology company, utilized AI to identify drugs with anti-aging properties, targeting multiple age-related biological pathways at once.

Trade Analysis of U.S. Anti-Aging Market: Trends & Investments

Growing innovations: To deal with the growing demand for anti-aging solutions, there is a growth in their research and development. This, in turn, is enhancing the development of novel products and therapies. These developments are further supported by the investments from various sources.

For instance,

• In September 2025, with a goal to extend human healthspan by 10 years using anti-aging therapies such as cellular reprogramming and AI-designed drugs, Retro Biosciences, which is a San Francisco startup backed by Sam Altman, is utilizing $1 billion in funding to accelerate the clinical trials for metabolic and Alzheimer's treatments. They are committed to redefining aging, despite regulatory hurdles.
• In May 2025, to target skin aging and cellular health by focusing on mitophagy, by developing innovative skin care solutions, a strategic investment and collaboration was announced between Vincere Biosciences and Beiersdorf. The research on an enzyme that regulates the removal of damaged mitochondria, USP30 of Vincere, will be combined with the expertise on the key antioxidant in mitochondrial health, coenzyme Q10 of Beiersdorf, in this collaboration.

Which are the New Anti-Aging Products Launched in the U.S. Aging Market?

Segmental Insights

Why the Topical Skincare Segment Dominated the U.S. Anti-Aging Market?

By product/treatment type, the topical skincare segment led the market with approximately 48% share in 2024, due to its wide range of availability. At the same time, they were easy to use and affordable. Moreover, the growing demand for non-invasive alternatives has increased their use.

By product/treatment type, the injectables segment is expected to show the highest growth during the upcoming years. Due to a growing shift in the aesthetic or beauty standards, they are being used as they are effective and provide long-term action. Additionally, the growing geriatric population is also increasing its use.

Which Channel/Distribution Type Segment Held the Dominating Share of the U.S. Anti-Aging Market in 2024?

By channel/distribution type, the retail segment held the dominating share of approximately 54% in the market in 2024, as it provides a wide range of products. This, in turn, helps the consumers to browse multiple options along with their ingredients and applications. Therefore, this increased accessibility enhanced the market growth.

By channel/distribution type, the medical aesthetics clinics/dermatology practices segment is expected to show the fastest growth rate during the predicted time. The presence of experts is increasing the trust among the clients, which is increasing their reliance. Additionally, minimally invasive options are also attracting the clients.

How the Women 35–64 Segment Dominated the U.S. Anti-Aging Market in 2024?

By age/demographic type, the women 35–64 segment dominated the market with approximately 60% share in 2024, driven by their visible aging signs. This, in turn, increased the use of a number of anti-aging solutions that maintain their appearance. Moreover, the growth in aesthetic awareness also increased their use.

By age/demographic type, the younger prevention (25–34) segment is expected to show the highest growth during the upcoming years. With the growing skin damage due to environmental factors, the demand for antiaging products is increasing. Moreover, the growing use of online platforms is also increasing the beauty standards, which is promoting their use

What Made Actives & Formulation Chemistry the Dominant Segment in the U.S. Anti-Aging Market in 2024?

By technology/science platform type, the actives & formulation chemistry segment held the largest share of approximately 50% in the market in 2024, due to their targeted action, which helped in minimizing the aging signs. Their enhanced efficacy and stability also increased their use. Additionally, the presence of products like serums, masks, etc, also attracted the consumers.

By technology/science platform type, the biotech-derived injectables & biostimulators segment is expected to show the fastest growth rate during the predicted time. They show a longer duration of action, increasing their acceptance rate. Moreover, their safety and non-invasive technique are also attracting the population.

Why Did the Individual Consumers (Retail Purchases) Segment Dominate in the U.S. Anti-Aging Market in 2024?

By end user/buyer type, the individual consumers (retail purchases) segment led the global market with approximately 54% share in 2024, driven by growing beauty awareness. The availability of a wide range of products also increased their purchase, enhancing their at-home use. Their affordability has also increased their adoption rate.

By end user/buyer type, the dermatology & medical aesthetic clinics segment is expected to show the highest growth during the upcoming years. The growing demand for minimally invasive treatments and for faster results is increasing, which is enhancing the use of their clinics. The presence of experts and advanced technologies is also enhancing client satisfaction.

Regional Insights

An aging population boosts the U.S.

The U.S. anti-aging market is expected to show significant growth due to the growth in the aging population. This, in turn, increased the use of various anti-aging products and therapies. At the same time, the growing awareness among the population is also increasing their demand for preventive care or cosmetics. Moreover, the healthcare investments are also enhancing their adoption rates as well as accelerating their innovations. Thus, this is promoting the market growth.

Global Anti-Aging Market Growth

The global anti-aging market is valued at about US$ 75.78 billion in 2024 and is expected to grow to US$ 79.97 billion in 2025. By 2034, it’s projected to reach nearly US$ 129.88 billion, reflecting a steady annual growth rate of 5.54%.

U.S. Anti-Aging Market Value Chain Analysis

R&D

The R&D of anti-aging focuses on the development of products, therapies, and technologies targeting molecular or cellular mechanisms to reverse the aging or delay it.

Key Players: L’Oréal Group, Johnson & Johnson, Unilever, The Estée Lauder Companies, Procter & Gamble.

Formulation and Final Dosage Preparation

Developing an effective formulation in the dosage form, such as serum, cream, or gel, is involved in the formulation and final dosage preparation of the anti-aging products.

Key Players: L’Oréal Group, Johnson & Johnson, Unilever, The Estée Lauder Companies, Procter & Gamble.

Patient Support and Services

The patient support and services of anti-aging solutions involve lifestyle guidance on nutrition and exercise, personalized consultations, aftercare for treatments, continuous monitoring, and educational resources.

Key Players: L’Oréal Group, Johnson & Johnson, Unilever, The Estée Lauder Companies, Procter & Gamble, Shiseido Company Ltd.

Top Vendors in the U.S. Anti-Aging Market & Their Offerings: 

• L’Oréal Group: The company provides various beauty products, body and skincare products, hair colour, pigmentation, hair styling, cleansers, and many other products. Their products are now used in various salons, pharmacies, and supermarkets.
• The Estée Lauder Companies: The company is well known for its high-quality skin care, hair care, makeup, and fragrance products. The company is focusing on innovative and creative product developments. 
• Procter & Gamble: The company provides products for beauty, grooming, health care, fabric & home care, baby, feminine & family care.
• Unilever: The company develops products such as beauty products, pharmaceuticals, healthcare and hygiene products, baby food, bottled water, breakfast cereals, cleaning agents, etc. Moreover, these products are categorized in four business groups, including beauty & wellbeing, personal care, nutrition, and home care.
• Johnson & Johnson / Neutrogena: The company provides various healthcare products. The company is also developing various anti-aging solutions along with other medicinal products.

Top Companies in the U.S. Anti-Aging Market

• Allergan Aesthetics
• Galderma
• Merz Aesthetics
• Revance Therapeutics
• InMode
• Cynosure
• Cutera
• Sciton/Lumenis/Alma Lasers
• Nestlé Health Science/NBTY/major nutraceutical suppliers
• Colgate-Palmolive
• The Ordinary/Deciem
• Dr. Fredric Brand/physician-led cosmeceutical brands
• Large DTC/e-commerce players
• Large dermatology clinic groups/medical aesthetics DSOs
• Specialty ingredient suppliers

What are the Recent Developments in the U.S. Anti-Aging Market?

• In June 2025, Telo-Vital, a natural longevity supplement, was launched by Touchstone Essentials. This nutraceutical utilizes organic botanicals and comprehensive research targeting the root cause of aging and was developed by Dr. Bill Andrews.
• In April 2025, Rapamycin (Sirolimus) Topical Facial Cream, used to combat skin aging at the cellular level, was launched by Los Angeles’ premier wellness and longevity destination that is IV Healing Spa. This formulation was developed in collaboration with the U.S.-based compounding pharmacy, focusing on the cellular science of rapamycin and the mTOR pathway.

Segments Covered in the Report

By Product/Treatment Type

• Topical Skincare (creams, lotions, serums)
• Nutraceuticals & Oral Supplements (collagen peptides, antioxidants)
• Injectables (neuromodulators + dermal fillers)
• Energy-based Devices & Equipment (lasers, RF, ultrasound)
• Prescription Topicals & Dermatology Therapies
• Cosmeceuticals / Professional Peels & In-office Treatments
• Regenerative Services (PRP, stem cell–adjacent therapies)
• Spa & Non-medical Services (facials, microdermabrasion)

By Channel/Distribution

• Retail (Online + Brick & Mortar)
• Medical Aesthetics Clinics/Dermatology Practices
• Pharmacies/Rx (prescription topicals)
• Specialty Retail & Spas
• Direct to Consumer/Subscription 

By Age/Demographic

• Women 35–64
• Men 35–64
• Younger prevention (25–34)

By Technology/Science Platform 

• Actives & formulation chemistry (retinoids, peptides)
• Biotech-derived injectables & biostimulators
• Device platforms (RF, lasers, HIFU)
• Nutriceutical ingredient platforms

By End User/Buyer Type

• Individual Consumers (Retail Purchases)
• Dermatology & Medical Aesthetic Clinics
• Spas & Wellness Centers
• Pharmacies & Hospitals
• OTC/eCommerce Subscriptions